
Quick Links
You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
国家医保局于11月28日正式公布《2024版NRDL目录》,安可坦®mHSPC新适应症实现医保准入,将会造福更多前列腺癌患者。...
时值2024年胃癌关爱月,安斯泰来(中国)投资有限公司(以下简称“安斯泰来中国”)以赞助形式支持福建省关癌有家恤病基金会及与癌共舞论坛在
2024年11月7日,第七届中国国际进口博览会同期活动——“品牌,让世界更美好”中外品牌论坛于上海召开,安斯泰来凭借在环境、社会和公司治理(E...
-安斯泰来VYLOY(zolbetuximab-clzb)获美国 FDA 批准用于治疗晚期胃和胃食管交界处(GEJ)腺癌...
Read more about 安斯泰来 VYLOY (zolbetuximab-clzb) 获美国 FDA 批准用于治疗晚期胃和胃食管交界处(GEJ)腺癌
北京,2024年9月27日...
